
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
— Hippocrates

The Getah virus (GETV) represent a growing concern for public health and the global livestock economy. As an emerging mosquito-borne arbovirus within the Alphavirus genus, it continues to expand its geographical footprint and host range. Understanding the molecular mechanisms behind Getah virus pathogenesis is essential for managing potential outbreaks. Recent research has now pinpointed the 3' untranslated region (3'UTR) as a vital regulator of viral fitness and transmission.
Researchers recently utilized a reverse genetics approach to dissect the functional role of the GETV 3'UTR. The study demonstrated that this region is remarkably plastic, allowing the virus to remain viable even after significant genetic deletions. However, the loss of conserved repeat sequence elements (RSEs) resulted in a cell-type-specific replication deficiency. Notably, these deletions also significantly attenuated the virus's virulence in murine models. Consequently, the modified viruses caused only minor illness compared to the high mortality seen with wild-type strains.
Beyond its role in host replication, the 3'UTR appears critical for vector competence. Specifically, a comprehensive deletion mutant named rGETV-KO310 showed a severe defect in early colonization within mosquito vectors. This finding suggests that the 3'UTR is necessary for efficient transmission between hosts. Furthermore, transcriptomic profiling revealed that the attenuation of the virus correlates with changes in how the host's immune system responds. The mutations specifically altered the modulation of the interferon and MAPK signaling pathways. Therefore, these insights provide a clear rationale for using targeted 3'UTR attenuation to develop safe and effective live-attenuated vaccine candidates.
Getah virus is an emerging zoonotic pathogen that primarily affects livestock, such as horses and pigs, but also poses an increasing risk to human populations in endemic regions.
The 3'UTR contains conserved elements that regulate viral replication efficiency and the ability of the virus to evade or modulate host immune responses like the interferon pathway.
By identifying specific regions of the 3'UTR that control virulence, scientists can create stable, attenuated versions of the virus that trigger immunity without causing severe disease.
Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional healthcare. Refer to the latest local and national guidelines for clinical practice.
References
Ren T et al. The 3'Untranslated region is a critical determinant of Getah virus replication, pathogenesis, and vector competence. Virulence. 2026 Jun 09. doi: 10.1080/21505594.2026.2687251. PMID: 42262762.
Lu G, Chen R, Shao R, Dong N, Liu W, Li S. Getah virus: an increasing threat in China. J Infect. 2020 Mar;80(3):350-371. doi: 10.1016/j.jinf.2019.11.016.
Folly AJ, et al. Global seroprevalence and distribution of Getah virus in domestic and wild animals: A systematic review and meta-analysis. Veterinary World. 2025 Nov;18(11). doi: 10.14202/vetworld.2025.2341-2356.
"
A study elucidates how the 3'UTR of Getah virus (GETV) regulates replication and virulence, offering a path for vaccine development....
3 days back

A recent study shows that seasonal vaccines boost antibody titres against H3N2 subclade K variants in adults. This research highlights why human serologic data is essential for accurate vaccine strain selection compared to ferret models.
Today

A nationwide Belgian study reveals that while invasive lobular carcinoma (ILC) has comparable 5-year survival to other breast cancers, its 10-year prognosis is significantly worse, particularly due to late recurrences in Luminal subtypes.
Today

Evidence suggests SGLT2 inhibitors may offer a disease-modifying strategy for aortic stenosis. By targeting valve calcification and myocardial remodeling, these drugs could slow disease progression and improve outcomes in patients with chronic pressure overload.
Today

A prospective study (SCOL Study) evaluates how different levels of anesthesia depth (BIS 60 vs 40) impact motor evoked potentials (TcMEP) in youths. Findings suggest that while deeper anesthesia alters signal parameters, it does not hinder successful surgeon-directed interpretation.
Today

Exploratory analyses of the JAVELIN Bladder 100 trial confirm that avelumab first-line maintenance significantly improves overall survival in advanced urothelial carcinoma patients with high BMI or diabetes mellitus, maintaining a consistent safety profile.
Today